FDA OKs Abbott Labs test for gonorrhea, chlamydia

Abbott Laboratories said Monday it received regulatory clearance to market new tests that can diagnose the sexually transmitted diseases gonorrhea and chlamydia.

Abbott said the Food and Drug Administration cleared the Abbott m2000 system, and the Abbott RealTime Chlamydia trachomatis/Neisseria gonorrhoeae test. They are used together to detect the diseases from specimens. The FDA also approved a specimen collection kit designed for use with the test and system.